Caloric Restriction and Activity to Reduce Chemoresistance in B-ALL
Part of paid clinical trials in Los Angeles, California.
- Sponsor
- Etan Orgel
- Study ID
- NCT05082519
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- B-cell Acute Lymphoblastic Leukemia
- Obesity
Eligibility Criteria
- Sex
- ALL
- Age
- 7 Years - 25 Years
- Healthy Volunteers
- Not accepted
Interventions
- IDEAL2 Intervention — BEHAVIORALIntervention of diet and exercise to improve outcomes for ALL patients
Study Details
This study is for older children, adolescents, and young adults with B-cell Acute Lymphoblastic Leukemia (B-ALL). Higher amounts of body fat is associated with resistance to chemotherapy in patients with B-ALL. Chemotherapy during the first month causes large gains in body fat in most people, even those who start chemotherapy at a healthy weight. This study is being done to find out if caloric restriction achieved by a personalized nutritional menu and exercise plan during routine chemotherapy can make the patient's ALL more sensitive to chemotherapy and also reduce the amount of body fat gained during treatment. The goals of this study are to help make chemotherapy more effective in treating the patient's leukemia as demonstrated by fewer patients with leukemia minimal residual disease (MRD) while also trying to reduce the amount of body fat that chemotherapy causes the patient to gain in the first month.
Key Dates
- First listed
- Oct 19, 2021
- Start date
- Mar 12, 2022
- Status verified
- Aug 2026
- Primary completion
- Aug 15, 2027
- Completion
- Aug 15, 2032
Study Design
- Enrollment
- 240 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- SUPPORTIVE_CARE
Arms
- Experimental: IDEAL2 interventionFocused and short-term intervention of diet and exercise during induction. Calorie goal is \>=15% daily deficit as determined by each subject's estimated energy requirement. Fat intake will make up \<25% of daily calories. Carbohydrate will make up \<55% of daily calories consisting of "low" glycemic load foods (\<100/2,000 kcal adjusted for daily calories). Protein will make up \>=20% of daily calories. Subjects will also perform moderate exercise 5 days per week for 30 minutes/session (total = 150 minutes per week). Subjects will have a step goal to decrease sedentary behavior, with a starting goal of \>=1000 steps/day and increasing by at least 1000 steps/day each week.
- No Intervention: Control - Standard of CareOne-time education of diet and exercise, which is the standard of care for ALL patients during induction.
Primary Outcome Measure
EOI MRD positivity >= 0.01% [ Time Frame: Prior to day 5 until end of induction (~day 35 from start of chemotherapy) ]
Central Contacts
- Ellynore Florendo323-361-3022
- Suganya Rajendran323-361-8835
Locations (16)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital Los Angeles | Los Angeles | California | 90027 | Etan Orgel, MD (PRINCIPAL_INVESTIGATOR) |
| Children's Hospital Orange County | Orange | California | 92868 | Van Huynh, MD (PRINCIPAL_INVESTIGATOR) |
| UCSF School of Medicine | San Francisco | California | 94158 | Michelle Hermiston, MD (PRINCIPAL_INVESTIGATOR) |
| Colorado Children's Hospital | Denver | Colorado | 80045 | Lisa Hartman, M.D. |
| Children's Healthcare of Atlanta at Egleston | Atlanta | Georgia | 30322 | Melinda Pauly, MD (PRINCIPAL_INVESTIGATOR) |
| Ann & Robert H. Lurie Children's Hospital of Chicago | Chicago | Illinois | 60611 | Jenna Rossoff, MD (PRINCIPAL_INVESTIGATOR) |
| Children's Mercy Hospital | Kansas City | Kansas | 64108 | Keith August, MD |
| C.S. Mott University of Michigan | Ann Arbor | Michigan | 48109 | Jennifer Agrusa, M.D. |
| Children's Hospitals and Clinics of Minnesota | Minneapolis | Minnesota | 55404 | Nathan Gossai, MD (PRINCIPAL_INVESTIGATOR) |
| Levine Children's Hospital | Charlotte | North Carolina | 28203 | Joel Kaplan, DO (PRINCIPAL_INVESTIGATOR) |
| Cincinnati Children's Hospital Medical Center | Cincinnati | Ohio | 45229 | Robin Norris, MD |
| Oregon Health & Science University | Portland | Oregon | 97239 | Bill Chang, MD (PRINCIPAL_INVESTIGATOR) |
| Children's Hospital of Philadelphia | Philadelphia | Pennsylvania | 19104 | Susan Rheingold, MD (PRINCIPAL_INVESTIGATOR) |
| University of Texas, Southwestern | Dallas | Texas | 75235 | Tamra Slone, MD |
| Baylor Texas Children's Hospital | Houston | Texas | 77030 | Karen Rabin, M.D. |
| Primary Children's Hospital | Salt Lake City | Utah | 84113 | Mallorie Heneghan, M.D. |
Find similar trials in Los Angeles, CA
Related Studies
- Identification of Phenotypic Factors That Predict Success for Weight Loss and Long-term Weight MaintenanceRecruiting · University of Michigan · Ann Arbor, Michigan
- Investigating the Impact of Obesity on Pubertal Development in GirlsRecruiting · National Institute of Environmental Health Sciences (NIEHS) · Research Triangle Park, North Carolina
- Inflammation, Diabetes, Ethnicity and Obesity CohortRecruiting · University of California, San Francisco · San Francisco, California
- Obesity, Metabolic Dysregulation and the Airway Epithelium in AsthmaticsRecruiting · University of Colorado, Denver · Aurora, Colorado